Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Are White men victims of their own top-dog status? Equity researchers eye provocative hypothesis through lens of health and wellbeing
Conventional wisdom holds that social standing and economic stability tend to manifest as long life, good health and optimal wellbeing. In the U.S., the subpopulation holding the most such power and footing is White men. So: What has happened to this demographic?
Consolidation of physician practices proceeds apace, corporatizing medicine one acquisition at a time
The days when most doctors worked in independent practice settings are fading from memory like old photoprints in a dog-eared scrapbook.
Key points to remember when performing cardiac ablations in ASCs
When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.
Patients are discussing whole-body MRIs on Reddit, presenting opportunity for radiologists
“Radiologists are well-positioned to contribute evidence-based guidance, promote transparency, and help patients make informed decisions," experts write in Clinical Imaging.
Lumexa acquires imaging center as part of new joint venture with UPMC
Lumexa hopes to open between 8 to 10 newly constructed, “de novo” centers in 2026, including multiple ones built in partnership with UPMC.

Half of emergency CT requests for children may not adhere to imaging appropriateness criteria

The overuse of CT scans on kids could be owed, at least in part, to the fear of missing a critical finding, new research suggests.

Makary out at FDA; food head Diamantas said to be stepping in

Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week.

SCAI is inviting younger female interventional cardiologists and fellows within five years of training to participate in the WONDER (Women Exposed to Occupational Doses of Radiation) study.

SCAI seeks female interventional cardiologists for radiation risk study

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic.

Attorneys aim to revive malpractice suit against radiologist using state’s ‘long-arm statute’

Jennifer Palmer died at age 34 after cancer spread to her bones, with her family subsequently suing a New York radiologist, alleging she missed sings on an MRI.

Radiology groups urge Congress to enact penalties against payers who violate No Surprises Act

ACR, the American Society of Neuroradiology, all 50 state medical societies and numerous others wrote to members of the U.S. House and Senate to express their frustrations on May 11.

Pharmacy owner gets 2 years in prison for defrauding Medicare of $2.5M

The former proprietor of a pharmacy in New Jersey was caught billing federal insurance for prescriptions of the antibiotic Dificid at $4,000 a pop, despite providers never ordering the pills. He pleaded guilty to charges of healthcare fraud conspiracy in November 2025.

Post-pandemic allowances for telehealth claims have not triggered runaway healthcare spending

If Congress doesn’t act soon, CMS’s flexible funding of telemedicine visits—a temporary holdover from the COVID era—will dry up next year. A new study may help persuade fiscally cautious representatives not to let that happen.

obesity semaglutide tirzepatide GLP-1 drugs weight loss

Weight loss drugs are hiking employer healthcare prices, with 87% saying they expect costs to only go up

In a survey, employers told the Business Group on Health that they aren’t yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

Management

Are White men victims of their own top-dog status? Equity researchers eye provocative hypothesis through lens of health and wellbeing

Consolidation of physician practices proceeds apace, corporatizing medicine one acquisition at a time

Key points to remember when performing cardiac ablations in ASCs

Patients are discussing whole-body MRIs on Reddit, presenting opportunity for radiologists

Lumexa acquires imaging center as part of new joint venture with UPMC